Designing heterotropically activated allosteric conformational switches using supercharging.
Allosteric Regulation
Calcium
/ chemistry
Cations, Divalent
/ chemistry
Cytochrome b Group
/ chemistry
Escherichia coli Proteins
/ chemistry
Hemeproteins
/ chemistry
Intrinsically Disordered Proteins
/ chemistry
Ligands
Magnesium
/ chemistry
Protein Conformation
Protein Engineering
/ methods
Protein Folding
Spermine
/ chemistry
Thermodynamics
allostery
intrinsically disordered proteins
ligand-induced folding
protein design
supercharging
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
10 03 2020
10 03 2020
Historique:
pubmed:
27
2
2020
medline:
14
7
2020
entrez:
27
2
2020
Statut:
ppublish
Résumé
Heterotropic allosteric activation of protein function, in which binding of one ligand thermodynamically activates the binding of another, different ligand or substrate, is a fundamental control mechanism in metabolism and as such has been a long-aspired capability in protein design. Here we show that greatly increasing the magnitude of a protein's net charge using surface supercharging transforms that protein into an allosteric ligand- and counterion-gated conformational molecular switch. To demonstrate this we first modified the designed helical bundle hemoprotein H4, creating a highly charged protein which both unfolds reversibly at low ionic strength and undergoes the ligand-induced folding transition commonly observed in signal transduction by intrinsically disordered proteins in biology. As a result of the high surface-charge density, ligand binding to this protein is allosterically activated up to 1,300-fold by low concentrations of divalent cations and the polyamine spermine. To extend this process further using a natural protein, we similarly modified
Identifiants
pubmed: 32098845
pii: 1916046117
doi: 10.1073/pnas.1916046117
pmc: PMC7071918
doi:
Substances chimiques
Cations, Divalent
0
Cytochrome b Group
0
Escherichia coli Proteins
0
Hemeproteins
0
Intrinsically Disordered Proteins
0
Ligands
0
Spermine
2FZ7Y3VOQX
cytochrome b562, E coli
9064-79-3
Magnesium
I38ZP9992A
Calcium
SY7Q814VUP
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
5291-5297Subventions
Organisme : NIMHD NIH HHS
ID : G12 MD007603
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM111932
Pays : United States
Déclaration de conflit d'intérêts
The authors declare no competing interest.
Références
Curr Opin Struct Biol. 1999 Aug;9(4):500-8
pubmed: 10449377
Biochemistry. 2013 Jan 22;52(3):447-55
pubmed: 23249163
Proc Natl Acad Sci U S A. 2010 May 4;107(18):8183-8
pubmed: 20404210
Nature. 2014 Apr 17;508(7496):331-9
pubmed: 24740064
Proteins. 2001 Jan 1;42(1):38-48
pubmed: 11093259
Chem Biol. 2015 Dec 17;22(12):1597-607
pubmed: 26628359
Nat Struct Biol. 1994 Jan;1(1):30-5
pubmed: 7656004
Biochemistry. 2015 Feb 17;54(6):1314-26
pubmed: 25631161
Inorg Chem. 2014 Jun 16;53(12):6309-20
pubmed: 24893204
Nat Rev Mol Cell Biol. 2005 Mar;6(3):197-208
pubmed: 15738986
J Biol Chem. 2016 Jul 15;291(29):14896-903
pubmed: 27268252
Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):9445-9450
pubmed: 28808010
J Struct Biol. 2014 Feb;185(2):178-85
pubmed: 23827257
Biopolymers. 1991 Jan;31(1):119-28
pubmed: 2025683
J Biol Chem. 2016 Mar 25;291(13):6696-705
pubmed: 26851279
J Am Chem Soc. 2006 Nov 15;128(45):14450-1
pubmed: 17090015
Biochemistry. 2008 Jul 22;47(29):7598-609
pubmed: 18627125
Biochemistry. 1997 Dec 23;36(51):16141-6
pubmed: 9405047
Biochemistry. 2012 Sep 18;51(37):7212-24
pubmed: 22897393
Cell Rep. 2014 Sep 25;8(6):1832-1844
pubmed: 25220455
J Biomol NMR. 1994 Mar;4(2):301-6
pubmed: 8019138
Nat Chem. 2010 Jan;2(1):15-24
pubmed: 21124375
Biochemistry. 2011 Nov 29;50(47):10254-61
pubmed: 22004125
Proteins. 2009 Feb 1;74(2):400-16
pubmed: 18636480